BioCentury
ARTICLE | Politics, Policy & Law

Pruning REGROW

How Senate Republican leaders are hoping to ease rules on regenerative therapies

October 17, 2016 7:00 AM UTC

Senate Republican leaders think FDA is unnecessarily impeding the development of regenerative medicines, and they want to use the 21st Century Cures Act as a vehicle to reduce regulatory requirements to market cell- and tissue-based therapies.

Sen. Majority Leader Mitch McConnell (R-Ky.) and Health, Education, Labor and Pensions (HELP) Committee Chairman Sen. Lamar Alexander (R-Tenn.) are leading the effort...